ArticleThe Journal of antimicrobial chemotherapy2017

Improved power for TB Phase IIa trials using a model-based pharmacokinetic-pharmacodynamic approach compared with commonly used analysis methods.

Robin J Svensson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.